P. Wermer, Genetic aspects of adenomatosis of endocrine glands, Am J Med, vol.16, issue.3, pp.363-371, 1954.

S. C. Chandrasekharappa, S. C. Guru, P. Manickam, S. E. Olufemi, F. S. Collins et al., Positional cloning of the gene for multiple endocrine neoplasia-type 1, Science, vol.276, issue.5311, pp.404-407, 1997.

S. Marx, A. M. Spiegel, M. C. Skarulis, J. L. Doppman, F. S. Collins et al., Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics, Ann Intern Med, vol.129, issue.6, p.484, 1998.
DOI : 10.7326/0003-4819-129-6-199809150-00011
URL : http://annals.org/data/journals/aim/19916/0000605-199809150-00011.pdf

K. Balogh, K. Rácz, A. Patócs, and L. Hunyady, Menin and its interacting proteins: elucidation of menin function, Trends Endocrinol Metab, vol.17, issue.9, pp.357-364, 2006.
DOI : 10.1016/j.tem.2006.09.004

Y. Yang and X. Hua, In search of tumor suppressing functions of menin, Mol Cell Endocrinol, pp.34-41, 2007.

K. Dreijerink, K. W. Mulder, G. S. Winkler, J. Höppener, C. Lips et al., Menin links estrogen receptor activation to histone H3K4 trimethylation, Cancer Res, vol.66, issue.9, pp.4929-4935, 2006.
DOI : 10.1158/0008-5472.can-05-4461
URL : http://cancerres.aacrjournals.org/content/canres/66/9/4929.full.pdf

H. Kim, J. Lee, E. Cho, J. O. Liu, H. Youn et al.,

, JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex, Cancer Res, vol.63, pp.6135-6139, 2003.

M. L. Brandi, R. F. Gagel, A. Angeli, J. P. Bilezikian, P. Beck-peccoz et al., Guidelines for diagnosis and therapy of MEN type 1 and type 2, J Clin Endocrinol Metab, vol.86, issue.12, pp.5658-5671, 2001.

F. Marini, A. Falchetti, D. Monte, F. , C. Sala et al., Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1), J Clin Endocrinol Metab, vol.1, issue.1, pp.2990-3011, 2006.

M. L. White and G. M. Doherty, Multiple Endocrine Neoplasia, Surg Oncol Clin N Am, vol.17, issue.2, pp.439-459, 2008.

P. Goudet, C. Bonithon-kopp, A. Murat, P. Ruszniewski, P. Niccoli et al., Cardot-Bauters C. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines, Eur J Endocrinol, vol.165, issue.1, pp.97-105, 2011.

L. Benson, S. Ljunghall, G. Akerström, and K. Oberg, Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1, Am J Med, vol.82, issue.4, pp.731-737, 1987.
DOI : 10.1016/0002-9343(87)90008-8

A. Calender, S. Giraud, P. Cougard, P. Chanson, G. Lenoir et al.,

, Multiple endocrine neoplasia type 1 in France: clinical and genetic studies, J Intern Med, vol.238, issue.3, pp.263-268, 1995.

D. Trump, B. Farren, C. Wooding, J. T. Pang, G. M. Besser et al., Clinical studies of multiple endocrine neoplasia type 1 (MEN1), QJM, vol.89, issue.9, pp.653-69, 1996.

J. Bassett, S. A. Forbes, A. Pannett, S. E. Lloyd, P. T. Christie et al., Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1, Am J Hum Genet, vol.62, issue.2, pp.232-244, 1998.

K. Dreijerink, P. Goudet, J. R. Burgess, and G. D. Valk, International Breast Cancer in MEN1 Study Group. Breast-cancer predisposition in multiple endocrine neoplasia type 1, N Engl J Med, vol.371, issue.6, pp.583-584, 2014.

J. Turner, P. T. Christie, S. Pearce, P. D. Turnpenny, and R. Thakker, Diagnostic challenges due to phenocopies: Lessons from Multiple Endocrine Neoplasia type1 (MEN1), Hum Mutat, issue.1, p.31, 2010.
DOI : 10.1002/humu.21170
URL : https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/humu.21170

C. Pieterman, J. Schreinemakers, H. Koppeschaar, M. R. Vriens, I. Rinkes et al., Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome, Clin Endocrinol
DOI : 10.1111/j.1365-2265.2008.03324.x

M. C. Lemos and R. V. Thakker, Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene, Hum Mutat, vol.29, issue.1, pp.22-32, 2008.

R. V. Thakker, Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4), Mol Cell Endocrinol, vol.386, issue.1-2, pp.2-15, 2014.
DOI : 10.1016/j.mce.2013.08.002
URL : https://doi.org/10.1016/j.mce.2013.08.002

J. Thevenon, A. Bourredjem, L. Faivre, C. Cardot-bauters, A. Calender et al., Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study, Eur J Endocrinol, vol.173, issue.6, pp.819-826, 2015.

J. Thevenon, A. Bourredjem, L. Faivre, C. Cardot-bauters, A. Calender et al., Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study, Hum Mol Genet, vol.22, issue.10, pp.1940-1948, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00935869

A. Pannett, A. Kennedy, J. Turner, S. Forbes, B. M. Cavaco et al., Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism, Clin Endocrinol (Oxf), vol.58, issue.5, pp.639-646, 2003.
DOI : 10.1046/j.1365-2265.2003.01765.x

W. S. Wassif, C. F. Moniz, E. Friedman, S. Wong, G. Weber et al., Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer, J Clin Endocrinol Metab, vol.77, issue.6, pp.1485-1489, 1993.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, 27. den Dunnen JT. Describing Sequence Variants Using HGVS Nomenclature, vol.17, pp.564-569, 2015.

M. Lenglet, F. Robriquet, K. Schwarz, C. Camps, A. Couturier et al., Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease, Blood, vol.132, issue.5, pp.469-483, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01833917

J. Turner, P. T. Christie, S. Pearce, P. D. Turnpenny, and R. Thakker, Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1), Hum Mutat, vol.31, issue.1, pp.1089-1101, 2010.
DOI : 10.1002/humu.21170
URL : https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/humu.21170

F. Desmet, D. Hamroun, M. Lalande, G. Collod-beroud, M. Claustres et al.,

, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, vol.37, issue.9, pp.67-67, 2009.

A. Cebrián, S. Ruiz-llorente, A. Cascón, M. Pollán, J. J. Díez et al., Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients, J Med Genet, vol.40, 2003.

J. M. De-laat, R. B. Van-der-luijt, C. Pieterman, M. P. Oostveen, A. R. Hermus et al., MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients, BMC Med, vol.14, issue.1, 2016.